Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Advaxis to Present at 2017 BIO International Convention | Business Wire
Advaxis and Biosight To Merge | citybiz
Advaxis Announces 1-for-80 Reverse Stock Split | citybiz
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy ...
Advaxis Unveils State-of-the-art Manufacturing Facility,
2013 Advaxis, Inc. | NASDAQ:ADXS Advaxis Approach: 4 Elements in 1 6 ...
Comecer signs an agreement for an aseptic system for Advaxis
Advaxis cuts staff as it seeks partner for troubled cancer vaccine ...
Advaxis gets green light for trial of Amgen-partnered neoantigen cancer ...
Advaxia Biologics - BIO International Convention | BIO
2013 Advaxis, Inc. | OTCQB:ADXS Advaxis Approach: 4 Elements in 1 6 ...
Cervivor visits Advaxis - Cervivor
Advaxis suffers another blow as FDA puts phase 3 on partial hold ...
2013 Advaxis, Inc. | OTCQB:ADXS 26 Advaxis , Inc. 305 College Road East ...
Advaxis Up on Positive Early-Stage Immunotherapy Study Data - Yahoo Sports
Advaxis Announces Executive Leadership Changes | Business Wire
Company Update: Advaxis Explores New Cancer Vaccines
O’Connor resigns as CEO of Advaxis with immediate effect | Fierce Biotech
Advaxis Appoints Al Blunt, M.D., as its Vice President of
PX'Therapeutics and ADVAXIS to collaborate for the process development ...
Advaxis and SELLAS Announce Licensing Agreement for
Advaxis looks to raise $20 million via share offering - New York ...
Advaxis (ADXS) Presents At LD Micro Main Event - Slideshow (OTCMKTS ...
Advaxis and Ayala Pharmaceuticals Complete Merger - BioSpace
Advaxis Jumps on Deal to Be Bought by Biosight - TheStreet
Advaxis Taps Kenneth Berlin as New CEO - BioSpace
Advaxis Stock Gives Every Indication Of Being Significantly Overvalued
Here's Why Advaxis Inc.'s Stock Roared Higher in March | Fox Business
Advaxis and Biosight in merger pact - BioTuesdays
Advaxis (ADXS.Q) and Biosight Enter into Definitive Merger Agreement ...
Ayala Pharmaceuticals completes merger with Advaxis - Philadelphia ...
Why Advaxis Gained 20% in 2015 | The Motley Fool
Advaxis Surges Higher on Additional Institutional Interest - TheStreet
Why Advaxis Stock Dropped 11% in July | The Motley Fool
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
Cute Bio Templates
2013 Advaxis, Inc. | NASDAQ:ADXS 27 Advaxis, Inc. 305 College Road East ...
Advaxia Biologics - IRBM
Destum Partners – Bridging the Gap Between Science and Business
Certara | Providing Around-the-Clock Regulatory Operations Support
Two Leading Biotech Publications Report on Advaxis’ Listeria Platform ...
[GRAPHIC MISSING]
Advaxis-Infographic – The Farrah Fawcett Foundation
Hearing Only What You Want to Hear | NTT STORY | NTT
Advaxis, Inc. Shares Close the Day 45.5% Higher - Daily Wrap | Nasdaq
Tiny Biotechnology Stock In Oncology Started A Huge Reversal ...
EX-99.1 2 v365476_ex99-1.htm EXHIBIT 99.1
Home // AdvaBio
9
2013 Advaxis, Inc. | NASDAQ:ADXS Ticker: ADXS Corporate Presentation ...
ADXS Stock Price and Chart — OTC:ADXS — TradingView
Here's Why Advaxis' Stock Gained 11% in October | Nasdaq
Thomas A. Moore Chairman and CEO 3 3
World Vaccine Congress Europe 2026 | Amsterdam
Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant ...
CELLULAR THERAPY - Haemopharm Healthcare
About Abivax | Abivax
Uterine cancer Archives - GEN - Genetic Engineering and Biotechnology News
ADVA Biotechnology | 進階生物科技股份有限公司
Advax augments B and T cell responses upon influenza vaccination via ...
Advatix 2026 Company Profile: Valuation, Funding & Investors | PitchBook
CommonStock
April 7,2015
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed ...
2013 Advaxis, Inc. | OTCQB:ADXS Ticker: ADXS September 2013 Corporate ...
Subscription Agreement (Shares) - What Is It, Explained, Examples
Immunotherapy in Advanced Non-Small Cell Lung Cancer
Small biotech Advaxis, on the brink of ruin, resurrects itself
Advaxis: Legit Reasons to Take Another Look at Under-Appreciated Cancer ...
Why Advaxis, Inc. Shares Are Soaring 11% Again Today | The Motley Fool
Why Advaxis, Inc Shares are Skyrocketing Today | Fox Business
Why Advaxis, Inc. Stock Rose 19.6% in May | Fox Business
Is Advaxis' Stock Now a Bargain? | The Motley Fool
ADXS-503(ADXS-503) - _专利_临床_研发
AXISBIO DIAGNOSTICS - Quality Solution for Life
About | StoneRidge Engineering, LLC.
.jpg?VersionId=B07p00HaW27ByBm6gP1Jjkej1yz8OXOY)
